<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Teva Pharmaceuticals on Turklegal IP - Turkish Patent and Trademark Attorneys</title><link>https://turklegal.com.tr/en/tags/teva-pharmaceuticals/</link><description>Recent content in Teva Pharmaceuticals on Turklegal IP - Turkish Patent and Trademark Attorneys</description><generator>Hugo -- gohugo.io</generator><language>en</language><lastBuildDate>Fri, 28 Aug 2026 10:47:36 +0300</lastBuildDate><atom:link href="https://turklegal.com.tr/en/tags/teva-pharmaceuticals/index.xml" rel="self" type="application/rss+xml"/><item><title>Turkish Competition Authority Launches Investigation into Teva Over Patent Strategies and Generic Competition</title><link>https://turklegal.com.tr/en/news/turkish-competition-authority-investigates-teva-patent-strategies/</link><pubDate>Fri, 28 Aug 2026 10:45:00 +0300</pubDate><author>Oktay Simsek</author><guid>https://turklegal.com.tr/en/news/turkish-competition-authority-investigates-teva-patent-strategies/</guid><description>&lt;p&gt;The Turkish Competition Authority, Rekabet Kurumu, has initiated a formal investigation into Teva İlaçları San. ve Tic. AŞ, Teva Pharmaceuticals Europe B.V., and Teva Pharmaceutical Industries Ltd. to determine whether the companies infringed Article 6 of the Turkish Competition Law by engaging in practices that may have restricted competition from generic medicines.&lt;/p&gt;</description></item></channel></rss>